Read our latest newsletter here.
Your email address will not be published. Required fields are marked *
Registered office address: 2 Michaels Court, Hanney Road, Southmoor, Abingdon, OX13 5HR. Matoke Holdings Company number: 07146235
A British biotechnology SME developing a new generation of antimicrobials based on our Reactive Oxygen® technology platform to combat AMR
Matoke Pharma supports the UK Government's recent 5-year AMR Strategy. Read our wider thoughts here: #AMR #StopSuperbugs
Matoke® Pharma welcomes UK Government’s 5-Year AMR Strategy - Matoke Holdings
Matoke® Pharma welcomes the UK’s recent 5-year action plan to tackle antimicrobial resistance (AMR).
Matoke Pharma welcomes the Government's 5-year #AMR Strategy. The battle to #StopSuperbugs requires measurable targets and a global, joined-up approach.
Superbugs don’t respect borders, and the UK’s new #AMR strategy will be vital to keeping people healthy all over the world.
Today @BillGates endorsed our vision for a world where #AntimicrobialResistance is controlled across the globe 🌍💊 #wef19
Globally, excellent research and work is ongoing to tackle #antimicrobial resistance. But will governments show the leadership our populations require? This article on the role vaccinations can play in #AMR is a great example of future opportunity:
Vaccinating Against Superbugs | by Seth Berkley & Jeremy Farrar
The ability to control infectious disease is the bedrock of modern medicine, and vaccines are important tools for keeping such diseases at bay. But va...
Matoke Holdings Limited, Matoke Holdings Limited logo, Reactive Oxygen, Reactive Oxygen with atom logo, RO and RO with atom logo are all trademarks of Matoke Holdings Limited.